Tag Archives: Hepatitis B

Arrowhead receives regulatory approval for trial of chronic hepatitis B drug

Hepatitis B

Tweet Arrowhead Research Corporation announced on Monday that it received regulatory approval from the Hong Kong Department of Health to begin Phase 2a clinical trials of hepatitis B virus treatment ARC-520. The certificate for clinical trial allows a single-dose study … Read More »

Filed in Medical Countermeasures | Tagged , | Comments Off

New mechanism could result in treatment for hepatitis B

Hepatitis B

Tweet A newly discovered mechanism could allow for new avenues for treating hepatitis B that do not damage infected liver cells, according to a study recently published in Science. While available antiviral medicines are able to control the hepatitis B … Read More »

Filed in Medical Countermeasures | Tagged , | Comments Off

Dynavax withdraws marketing application for hepatitis B vaccine

dynavax technologies

TweetDynavax, a Berkeley, California-based clinical-stage biopharmaceutical company, announced on Tuesday that it withdrew its European marketing authorization application for its investigational hepatitis B vaccine. HEPLISAV is an investigational adult hepatitis B vaccine that combines a proprietary toll-like receptor 9 agonist … Read More »

Filed in Vaccine Development | Tagged , | Comments Off

Hepatitis B Foundation welcomes Robert Gish as medical director

Hepatitis B Foundation

TweetThe Hepatitis B Foundation announced on Thursday that Robert G. Gish was named the nonprofit foundation’s medical director on Jan. 30. The foundation said Gish has made invaluable contributions to understanding and the treatment of hepatitis B, which is the … Read More »

Filed in Medical Countermeasures | Tagged | Comments Off

New study finds HBV-infected men more likely to develop liver cancer

Hepatitis B

Tweet A team of researchers from Seoul National University in Korea recently found a novel mutation in the hepatitis B virus that appears only in men and makes men more susceptible to the development of liver cancer. The study may … Read More »

Filed in Medical Countermeasures | Tagged , | Comments Off

Hepatitis B research center renamed for co-founder Baruch Blumberg

Hepatitis B

Tweet The Doylestown, Pennsylvania-based Hepatitis B Foundation announced on Wednesday the renaming of its research institute to honor the scientific legacy of the foundation’s co-founder, the late Baruch Blumberg. Blumberg won the Nobel Prize in medicine in 1976 for his … Read More »

Filed in News | Tagged | 2 Comments

ARC successfully completes Phase I trial of hepatitis B drug ARC-520

arrowhead research corporation

TweetArrowhead Research Corporation announced on Wednesday that it successfully completed enrollment in a Phase I clinical trial of its RNAi-based candidate drug, ARC-520, against chronic hepatitis B virus infection. The preliminary testing showed that ARC-520 is generally well tolerated and … Read More »

Filed in Medical Countermeasures | Tagged , | 1 Comment

Roche and Inovio partner in the fight against prostate cancer and hepatitis B


TweetRoche and Inovio Pharmaceuticals, Inc., announced on Tuesday that the companies entered into a global license agreement to conduct research, develop and market Inovio’s immunotherapies for prostate cancer and hepatitis B. Roche obtained an exclusive license for Inovio’s DNA-based vaccines … Read More »

Filed in Medical Countermeasures | Tagged , | Comments Off

New study shines light on fight against hepatitis C and hepatitis B

Arrowhead starts Phase I trial of hepatitis B therapeutic

Study shows HBV co-infections can predict prognosis

Investor sues Dynavax

Hep B United and CDC team up for multilingual testing campaign

New initiative raises Hepatitus B vaccine awareness

Dynavax Technologies has conference call with FDA on HEPLISAV vaccine

DHEC Hepatitis B investigation continues

Qasim: We must reach all Somali children with vaccines

Somalia will receive new pentavalent vaccine

British Columbia to follow HIV model to treat viral hepatitis

Arrowhead reduces 90 percent of hepatitis B antigens in chimpanzee study

Hepatitis B rates on the rise in Vietnam

Stanford and Silicon Valley team up to battle hepatitis B

Indian district hit with hepatitis B vaccine shortage

Doctors in India express concern over rising hepatitis B cases

West Virginia county participates in hepatitis B vaccination pilot program

Study: One-third of hepatitis B and C cases in Pakistan are preventable

Iowa man pleads guilty in fake hepatitis B case

Researchers block previously unstudied hepatitis B enzyme

Rwanda commissions study on hepatitis B prevalence

U.S. seniors hit hard by hepatitis B

HBV decreasing in Morocco

Buffalo VA may have been exposed to hepatitis, HIV